secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001493152-23-024401
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic closes $1.0M debt-to-equity conversion; issues 40 Units with notes and warrants
--------------------------------------------------------------------------------

- Converted $1.0M of debt via private placement of 40 Units to accredited investors.
- Each Unit: $25K convertible note (16% interest, 2-yr, $0.10 conversion) and 250K warrants at $0.12/share.
- Total offering up to 200 Units ($5M); placement agent JH Darbie, $150K fees paid.
- Securities unregistered, exempt under Rule 506(b); Registration Rights Agreement filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315223024401/0001493152-23-024401-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315223024401/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024401

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer